Trial Profile
A Phase I/II Clinical Trial Assessing Safety and Efficacy of BZL101 For Metastatic Breast Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs BZL 101 (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 15 Mar 2012 Actual patient number 27 added as reported by ClinicalTrials.gov.
- 15 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jan 2010 Results presented in a Bionovo media release.